Startups · AI

Translational ML Scientist

Evvy · New York City · On-site

← All jobs
About Evvy

Get innovative vaginal healthcare, powered by our state-of-the-art Vaginal Microbiome Test. Our clinical care platform includes Rx for bacterial vaginosis (BV), yeast infections, aerobic vaginitis, fertility and more. Trusted by 100,000+ users. Backed by General Catalyst.

About the role

We’re looking for a Senior ML Translational Scientist to help turn Evvy’s microbiome data into the diagnostic and prognostic tools that power our products. You’ll work with the world’s largest dataset on the vaginal microbiome paired with longitudinal symptom, treatment, and outcomes data. The opportunity is to move beyond analysis and build models that become part of real clinical and patient-facing products.

What they're looking for

  • 5–8 years of post-PhD or post-MS experience building ML models on biological data, PhD in computational biology, bioinformatics, machine learning, statistics, or a related field strongly preferred (we're open to exceptional MS candidates)
  • Genuinely strong in both machine learning and computational biology. You can hold your own in a methods discussion with ML engineers and in a biology discussion with researchers
  • Industry experience shipping ML or computational biology models, not just publishing them. You've built things that ran in production and served real users
  • Hands-on fluency in Python and modern ML frameworks (PyTorch, scikit-learn, and similar), and with microbiome-specific tools (QIIME2, MetaPhlAn, HUMAnN, or similar)
  • Deep familiarity with the realities of microbiome data, including compositional data, sparsity, batch effects, and the difference between taxonomic and functional profiles
  • A strong product instinct. You understand that the deliverable isn't the model, it's the feature or diagnostic the model enables
More about this role

At Evvy, we believe the female body shouldn’t be a medical mystery.

We are a precision women’s health company leveraging the vaginal microbiome to improve outcomes across a woman's lifespan. Backed by $60M+ from leading investors, we serve over 100,000 patients and 3,000 providers nationwide with our validated Vaginal Microbiome Test and AI-powered personalized care platform.

Through this work, we have built the world’s largest dataset on the vaginal microbiome — a proprietary foundation that will drive breakthroughs in infertility, preterm birth, gynecological cancers, and beyond.

Evvy is a generational opportunity in women's health — and we're at the inflection point.

We’ve built a dataset no one has. Evvy has generated the world’s largest vaginal microbiome dataset from 100,000+ patients, uncovering novel biological markers underlying women’s health conditions that collectively cost the healthcare system $180B+ annually.

Validated, AI-first platform. We’ve built a comprehensive testing and care platform that unlocks personalized treatment pathways for each patient. Our work is supported by research published in major peer-reviewed journals and presented at major clinical...

Read the full posting on Evvy's site ↗

Science / R&D

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.